Pore-Forming Neurotoxin-Like Mechanism for Aβ Oligomer-Induced Synaptic Failure

Author(s):  
Luis G. Aguayo ◽  
Jorge Parodi ◽  
Fernando J. Sepúlveda ◽  
Carlos Opazo
2021 ◽  
pp. 1-17
Author(s):  
Wanyi Huang ◽  
Fan Zeng ◽  
Yebo Gu ◽  
Muzhou Jiang ◽  
Xinwen Zhang ◽  
...  

Background: Studies have reported that synaptic failure occurs before the Alzheimer’s disease (AD) onset. The systemic Porphyromonas gingivalis (P. gingivalis) infection is involved in memory decline. We previously showed that leptomeningeal cells, covering the brain, activate glial cells by releasing IL-1β in response to systemic inflammation. Objective: In the present study, we focused on the impact of leptomeningeal cells on neurons during systemic P. gingivalis infection. Methods: The responses of leptomeningeal cells and cortical neurons to systemic P. gingivalis infection were examined in 15-month-old mice. The mechanism of IL-1β production by P. gingivalis infected leptomeningeal cells was examined, and primary cortical neurons were treated with P. gingivalis infected leptomeningeal cells condition medium (Pg LCM). Results: Systemic P. gingivalis infection increased the expression of IL-1β in leptomeninges and reduced the synaptophysin (SYP) expression in leptomeninges proximity cortex in mice. Leptomeningeal cells phagocytosed P. gingivalis resulting in lysosomal rupture and Cathepsin B (CatB) leakage. Leaked CatB mediated NLRP3 inflammasome activation inducing IL-1β secretion in leptomeningeal cells. Pg LCM decreased the expression of synaptic molecules, including SYP, which was inhibited by an IL-1 receptor antagonist pre-treatment. Conclusion: These observations demonstrate that P. gingivalis infection is involved in synaptic failure by inducing CatB/NLRP3 inflammasome-mediated IL-1β production in leptomeningeal cells. The periodontal bacteria-induced synaptic damage may accelerate the onset and cognitive decline of AD.


Neuropeptides ◽  
2018 ◽  
Vol 67 ◽  
pp. 27-35 ◽  
Author(s):  
Tina Dunkelmann ◽  
Kerstin Teichmann ◽  
Tamar Ziehm ◽  
Sarah Schemmert ◽  
Daniel Frenzel ◽  
...  
Keyword(s):  

2018 ◽  
Vol 115 (41) ◽  
pp. 10245-10250 ◽  
Author(s):  
Sean Chia ◽  
Johnny Habchi ◽  
Thomas C. T. Michaels ◽  
Samuel I. A. Cohen ◽  
Sara Linse ◽  
...  

To develop effective therapeutic strategies for protein misfolding diseases, a promising route is to identify compounds that inhibit the formation of protein oligomers. To achieve this goal, we report a structure−activity relationship (SAR) approach based on chemical kinetics to estimate quantitatively how small molecules modify the reactive flux toward oligomers. We use this estimate to derive chemical rules in the case of the amyloid beta peptide (Aβ), which we then exploit to optimize starting compounds to curtail Aβ oligomer formation. We demonstrate this approach by converting an inactive rhodanine compound into an effective inhibitor of Aβ oligomer formation by generating chemical derivatives in a systematic manner. These results provide an initial demonstration of the potential of drug discovery strategies based on targeting directly the production of protein oligomers.


Aging ◽  
2021 ◽  
Vol 13 (5) ◽  
pp. 6634-6661
Author(s):  
Fang Chen ◽  
Shunchang Fang ◽  
Yifeng Du ◽  
Arijit Ghosh ◽  
Miranda N. Reed ◽  
...  

2015 ◽  
Vol 11 (7S_Part_6) ◽  
pp. P305-P305
Author(s):  
Timothy M. Ryan ◽  
Blaine R. Roberts ◽  
Gawain McColl ◽  
Dominic J. Hare ◽  
Mark G. Hinds ◽  
...  

2014 ◽  
Vol 125 (2) ◽  
pp. 255-262 ◽  
Author(s):  
Marleen C. Tjepkema-Cloostermans ◽  
Rikkert Hindriks ◽  
Jeannette Hofmeijer ◽  
Michel J.A.M. van Putten

2017 ◽  
Vol 13 (7S_Part_13) ◽  
pp. P662-P663
Author(s):  
Christina M. Coughlan ◽  
Athena Wang ◽  
Lisa Viltz ◽  
Heidi J. Chial ◽  
Huntington Potter

Sign in / Sign up

Export Citation Format

Share Document